BACKGROUND: Transradial access (TRA) is associated with improved survival and reduced vascular complications in acute myocardial infarction (AMI). Limited data exist regarding TRA utilization and outcomes for AMI complicated by cardiogenic shock (CS). We sought to assess the safety, feasibility, and clinical outcomes of TRA in AMI-CS. METHODS: One-hundred and fifty-three patients with AMI-CS were stratified into tertiles of disease severity using the CardShock score. The primary endpoint was successful percutaneous coronary intervention (PCI), defined as Thrombolysis in Myocardial Infarction III flow with survival to 30 days. RESULTS: Mean age was 66 years, 72% were men, and 47% had diabetes. TRA was the preferred access site in patients with low and intermediate disease severity. Overall, 50 (32%) patients experienced major adverse cardiac and cerebrovascular events; most events (78%) occurred in patients undergoing transfemoral access (TFA) in the intermediate-high tertiles of CS severity. Of the 41 (27%) total bleeding events, 32% occurred at the coronary angiography access site, of which 92% were in the TFA group. The use of ultrasound (US) guidance for TFA resulted in reduced coronary access-site bleeding (8.5 vs. 33.0%, p = .01). In a hierarchical logistic regression model, utilizing TRA did not result in lower odds of successful PCI (Odds ratio [OR]: 1.36; 95% confidence interval [CI]: 0.54-3.40). CONCLUSION: This study suggests that TRA is feasible across the entire spectrum of AMI-CS and is associated with reduced coronary access-site bleeding. In addition, US-guided TFA is associated with reductions in access-site bleeding and vascular complications. Concerted efforts should be made to incorporate vascular access protocols into existing CS algorithms in dedicated shock care centers.
BACKGROUND: Transradial access (TRA) is associated with improved survival and reduced vascular complications in acute myocardial infarction (AMI). Limited data exist regarding TRA utilization and outcomes for AMI complicated by cardiogenic shock (CS). We sought to assess the safety, feasibility, and clinical outcomes of TRA in AMI-CS. METHODS: One-hundred and fifty-three patients with AMI-CS were stratified into tertiles of disease severity using the CardShock score. The primary endpoint was successful percutaneous coronary intervention (PCI), defined as Thrombolysis in Myocardial Infarction III flow with survival to 30 days. RESULTS: Mean age was 66 years, 72% were men, and 47% had diabetes. TRA was the preferred access site in patients with low and intermediate disease severity. Overall, 50 (32%) patients experienced major adverse cardiac and cerebrovascular events; most events (78%) occurred in patients undergoing transfemoral access (TFA) in the intermediate-high tertiles of CS severity. Of the 41 (27%) total bleeding events, 32% occurred at the coronary angiography access site, of which 92% were in the TFA group. The use of ultrasound (US) guidance for TFA resulted in reduced coronary access-site bleeding (8.5 vs. 33.0%, p = .01). In a hierarchical logistic regression model, utilizing TRA did not result in lower odds of successful PCI (Odds ratio [OR]: 1.36; 95% confidence interval [CI]: 0.54-3.40). CONCLUSION: This study suggests that TRA is feasible across the entire spectrum of AMI-CS and is associated with reduced coronary access-site bleeding. In addition, US-guided TFA is associated with reductions in access-site bleeding and vascular complications. Concerted efforts should be made to incorporate vascular access protocols into existing CS algorithms in dedicated shock care centers.
Authors: Sunil V Rao; Jennifer A Tremmel; Ian C Gilchrist; Pinak B Shah; Rajiv Gulati; Adhir R Shroff; Van Crisco; Walter Woody; Gilbert Zoghbi; Peter L Duffy; Kintur Sanghvi; Mitchell W Krucoff; Christopher T Pyne; Kimberly A Skelding; Tejas Patel; Samir B Pancholy Journal: Catheter Cardiovasc Interv Date: 2013-10-23 Impact factor: 2.692
Authors: Holger Thiele; Ibrahim Akin; Marcus Sandri; Georg Fuernau; Suzanne de Waha; Roza Meyer-Saraei; Peter Nordbeck; Tobias Geisler; Ulf Landmesser; Carsten Skurk; Andreas Fach; Harald Lapp; Jan J Piek; Marko Noc; Tomaž Goslar; Stephan B Felix; Lars S Maier; Janina Stepinska; Keith Oldroyd; Pranas Serpytis; Gilles Montalescot; Olivier Barthelemy; Kurt Huber; Stephan Windecker; Stefano Savonitto; Patrizia Torremante; Christiaan Vrints; Steffen Schneider; Steffen Desch; Uwe Zeymer Journal: N Engl J Med Date: 2017-10-30 Impact factor: 91.245
Authors: Behnam N Tehrani; Alexander G Truesdell; Matthew W Sherwood; Shashank Desai; Henry A Tran; Kelly C Epps; Ramesh Singh; Mitchell Psotka; Palak Shah; Lauren B Cooper; Carolyn Rosner; Anika Raja; Scott D Barnett; Patricia Saulino; Christopher R deFilippi; Paul A Gurbel; Charles E Murphy; Christopher M O'Connor Journal: J Am Coll Cardiol Date: 2019-04-09 Impact factor: 24.094
Authors: Veli-Pekka Harjola; Johan Lassus; Alessandro Sionis; Lars Køber; Tuukka Tarvasmäki; Jindrich Spinar; John Parissis; Marek Banaszewski; Jose Silva-Cardoso; Valentina Carubelli; Salvatore Di Somma; Heli Tolppanen; Uwe Zeymer; Holger Thiele; Markku S Nieminen; Alexandre Mebazaa Journal: Eur J Heart Fail Date: 2015-03-28 Impact factor: 15.534
Authors: Adhir R Shroff; Rajiv Gulati; Douglas E Drachman; Dmitriy N Feldman; Ian C Gilchrist; Prashant Kaul; Kusum Lata; Samir B Pancholy; Carmelo J Panetta; Arnold H Seto; Bernadette Speiser; Daniel H Steinberg; Mladen I Vidovich; Walter W Woody; Sunil V Rao Journal: Catheter Cardiovasc Interv Date: 2019-12-27 Impact factor: 2.692
Authors: J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel Journal: N Engl J Med Date: 1999-08-26 Impact factor: 91.245
Authors: Peter J Mason; Binita Shah; Jacqueline E Tamis-Holland; John A Bittl; Mauricio G Cohen; Jordan Safirstein; Douglas E Drachman; Javier A Valle; Denise Rhodes; Ian C Gilchrist Journal: Circ Cardiovasc Interv Date: 2018-09 Impact factor: 6.546
Authors: Enrico Romagnoli; Maria De Vita; Francesco Burzotta; Bernardo Cortese; Giuseppe Biondi-Zoccai; Francesco Summaria; Roberto Patrizi; Chiara Lanzillo; Valerio Lucci; Caterina Cavazza; Fabio Tarantino; Giuseppe M Sangiorgi; Ernesto Lioy; Filippo Crea; Sunil V Rao; Carlo Trani Journal: Am Heart J Date: 2013-10-10 Impact factor: 4.749
Authors: Eltigani Abdelaal; Cynthia Brousseau-Provencher; Sarah Montminy; Guillaume Plourde; Jimmy MacHaalany; Yoann Bataille; Pierre Molin; Jean-Pierre Déry; Gérald Barbeau; Louis Roy; Éric Larose; Robert De Larochellière; Can M Nguyen; Guy Proulx; Olivier Costerousse; Olivier F Bertrand Journal: JACC Cardiovasc Interv Date: 2013-10-16 Impact factor: 11.195
Authors: Ole Kristian Lerche Helgestad; Jakob Josiassen; Christian Hassager; Lisette Okkels Jensen; Lene Holmvang; Nanna Louise Junker Udesen; Henrik Schmidt; Hanne Berg Ravn; Jacob Eifer Moller Journal: Open Heart Date: 2020-03-04
Authors: Muhammad Junaid Ahsan; Soban Ahmad; Azka Latif; Noman Lateef; Mohammad Zoraiz Ahsan; Waiel Abusnina; Sandeep Nathan; S Elissa Altin; Dhaval S Kolte; John C Messenger; Mark Tannenbaum; Andrew M Goldsweig Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-09-05
Authors: Behnam N Tehrani; Alexander G Truesdell; Mitchell A Psotka; Carolyn Rosner; Ramesh Singh; Shashank S Sinha; Abdulla A Damluji; Wayne B Batchelor Journal: JACC Heart Fail Date: 2020-11 Impact factor: 12.035